Vertigo including BPPV can have lasting burden even after treatment, study finds

Authors concluded that although BPPV was often considered a benign and easily treatable condition, long-term monitoring may be necessary due to the high rates of recurrence and residual symptoms. Image: Andrey Popov/stock.adobe.com. A long-term study has found that benign paroxysmal positional vertigo (BPPV) can continue to affect patients for years after successful treatment, with many experiencing recurrent...

Audiologists and vestibular clinicians should consider scheduling long-term follow-up for BPPV patients, as high recurrence rates and residual symptoms mean a single successful repositioning treatment may not mark the end of a patient's clinical journey.

Reframing BPPV as a potentially chronic, recurring condition rather than a one-and-done diagnosis has significant implications for vestibular care pathways and patient counselling in audiology and ENT settings.

1. 01BPPV (a common inner-ear disorder causing brief spinning sensations) has high recurrence rates even after successful treatment.
2. 02Residual symptoms persist in a meaningful proportion of patients post-treatment.
3. 03The study challenges the widely held view that BPPV is reliably 'cured' after repositioning manoeuvres.
4. 04Findings support the need for structured long-term monitoring protocols for BPPV patients.
5. 05Ongoing burden includes both physical symptoms and likely quality-of-life impact.

Publication type

research_article

Evidence level

2b

Population

Patients diagnosed with BPPV and/or vertigo followed over a long-term period post-treatment

Intervention

Standard BPPV treatment (e.g., canalith repositioning manoeuvres)